Breaking News, Collaborations & Alliances

Bio-Thera & SteinCares Ink Dupilumab Biosimilar Deal for Latin America

Collaboration aims to commercialize a proposed biosimilar of dupilumab across Latin America.

Author Image

By: Charlie Sternberg

Associate Editor

Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and SteinCares, a specialty healthcare company in Latin America, have signed a new agreement to commercialize a proposed biosimilar of dupilumab across Latin America. Under the agreement, Bio-Thera will be responsible for product development and supply, while SteinCares will lead the registration and commercialization process throughout Latin America. Dupil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters